Cargando…
Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases
PURPOSE: Interleukin-6 (IL-6) production and signalling are increased in the inflamed mucosa in inflammatory bowel diseases (IBD). As published serum levels of IL-6 and its soluble receptors sIL-6R and sgp130 in IBD are from small cohorts and partly contradictory, we systematically evaluated IL-6, s...
Autores principales: | Nikolaus, Susanna, Waetzig, Georg H., Butzin, Sven, Ziolkiewicz, Monika, Al-Massad, Natalie, Thieme, Florian, Lövgren, Ulf, Rasmussen, Birgitte B., Reinheimer, Torsten M., Seegert, Dirk, Rosenstiel, Philip, Szymczak, Silke, Schreiber, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002455/ https://www.ncbi.nlm.nih.gov/pubmed/29748708 http://dx.doi.org/10.1007/s00384-018-3069-8 |
Ejemplares similares
-
Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
por: Jablonska, E, et al.
Publicado: (2003) -
Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy
por: Chen, Hui, et al.
Publicado: (2016) -
Associations between the IL-6-neutralizing sIL-6R-sgp130 buffer system and coronary artery disease in postmenopausal women
por: Zhou, Man, et al.
Publicado: (2020) -
Associations between serum estradiol and IL-6/sIL-6R/sgp130 complex in female patients with major depressive disorder
por: Sun, Ting, et al.
Publicado: (2023) -
Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)
por: Schulte, Dominik M., et al.
Publicado: (2022)